Feedback / Questions
Reolysin (pelareorep) - Oncolytics, Andrus Reo
https://www.prnewswire.com/news-releases/oncolytics-biotech-to-present-new-clinical-trial-data-at-asco-showing-pelareoreps-unique-immune-activation-capabilities-302464177.html
May 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next